Key result
Hypertension is linked to elevated beta-TG/PF4 ratios and triglycerides, indicating increased in vivo platelet activation.
Why the study?
Do platelet specific proteins and lipid profiles differ across stages of hypertension compared to normotensive controls?
Cross-Sectional (n=108)
Do platelet specific proteins and lipid profiles differ across stages of hypertension compared to normotensive controls?
Beta-TG/PF4 ratio and triglycerides are closely related to the stage of hypertension, serving as indicators of in vivo platelet activation which may contribute to atherogenesis.
Answers are grounded in this paper and cite their sources.
Stage III hypertension links to heightened platelet activation; leaves open whether beta-TG/PF4 ratio refines atherothrombotic risk prediction.
There is considerable evidence from previous studies that platelets play an important role in the development and progression of atherosclerosis in hypertension, more so in relation to the stage of hypertension. Seventy one hypertensive patients (WHO stage I: 39, stage II: 23, stage III: 9) aged 19-84 (mean age: 56, 59 and 62 respectively for each stage) and 37 normal controls (aged 22-72 with a mean age of 52) were involved in this study. Hematocrit, beta-thromboglobulin (beta-TG), platelet factor 4 (PF4), beta-TG/PF4 ratio, total cholesterol (TC), low density lipoprotein-C, and triglycerides were higher in the hypertensive group while platelet count, circulating platelet aggregates, and high density lipoprotein-C were higher in the normotensive group. Among the hypertensives, stage III patients showed the highest beta-TG, PF4, beta-TG/PF4 ratio, triglycerides, and stage I with the least elevation. There were no significant differences noted in the ADP or epinephrine-induced platelet aggregation in both the normal and hypertensive patients. Other parameters such as heart rate, serum sodium, potassium, renal and liver function tests, plasma renin activity, aldosterone, fibrinogen thromboxane B2 and 6-Keto-PGF1 alpha, showed no significant differences in both groups. This study clearly showed that beta-TG/PF4 ratio and triglycerides are closely related to the stage of hypertension and are good indicators of in vivo platelet activation in hypertensives which may account for the acceleration of hypertensive vascular complications secondary to atherogenesis.
No takes yet. Share an insight, caveat, or question.
Ding et al. (1991) conducted a cross-sectional in Hypertension and Atherosclerosis (n=108). Hypertension vs. Normotensive controls was evaluated on Platelet specific proteins (beta-TG, PF4) and lipid profiles. Hypertension, particularly stage III, was associated with elevated beta-TG/PF4 ratios and triglycerides compared to normotensive controls, indicating increased in vivo platelet activation.
Synapse has enriched 10 related papers. Consider them for comparative context: